StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) shareholders

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
39.2%
140M of 358M shares
Institutional holders
211
37 new, 28 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
1 buys · 42 sales
Net sold $44.76M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Randal J. Kirk
Joint filing with R.J. Kirk Declaration Of Trust (26.10%), Third Security, LLC (5.90%)
133,956,41635.90%13D (active) amendmentMar 30, 2026
Patient Capital Management, LLC
Joint filing with Patient Opportunity Trust, a Series of Advisor Managed Portfolios (7.80%)
36,006,80010.20%13G (passive) amendmentDec 31, 2025
William H. Miller III Living Trust dated April 17, 201734,051,9259.20%13G (passive)Jun 26, 2025
Ares Trading SA
Joint filing with Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany (8.30%), Merck KGaA, Darmstadt, Germany (8.30%) and 1 more
20,647,1528.30%13G (passive) amendmentFeb 14, 2024
Steven A. Cohen
Joint filing with Point72 Asset Management, L.P. (5.20%), Point72 Capital Advisors, Inc. (5.20%)
18,383,2425.20%13G (passive)Jan 22, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PGENValueChange% of portfolio
Patient Capital Management, LLC19,036,9765.32%$108.51M+1,219,5893.56%
BlackRock, Inc.17,146,9214.79%$97.74M+1,923,7300.00%
State Street Corp12,002,4653.35%$68.41M+1,112,3410.00%
Diametric Capital, LP9,269,9262.59%$52.84M+2,468,1385.57%
Vanguard Capital Management LLC7,906,1602.21%$45.07M+757,1640.00%
Tang Capital Management LLC6,417,5001.79%$36.58M–1.66%
Boxer Capital Management, LLC5,150,0001.44%$29.36M+1,650,0002.21%
Geode Capital Management, LLC5,019,0281.40%$28.61M+405,5990.00%
Iridian Asset Management LLC/Ct4,031,9631.13%$22.98M+439,2337.90%
Occam Crest Management LP3,605,9411.01%$19.65M−663,11010.20%
Morgan Stanley3,469,6280.97%$19.78M+1,055,3060.00%
Goldman Sachs Group Inc3,406,4560.95%$19.42M+55,9790.00%
FMR LLC2,570,1830.72%$14.65M+571,5870.00%
Vanguard Portfolio Management LLC2,211,1720.62%$12.60M+95,1610.00%
First Trust Advisors LP2,014,6590.56%$11.48MNew0.01%
Bank Of America Corp /De/1,848,4140.52%$10.54M+377,1350.00%
Arrowstreet Capital, Limited Partnership1,788,2350.50%$10.19M+1,392,5400.00%
Northern Trust Corp1,779,3800.50%$10.14M+167,5900.00%
Charles Schwab Investment Management Inc1,515,8530.42%$8.64M+55,2330.00%
Woodline Partners LP1,401,9450.39%$7.99M+5330.02%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026211140M39.2%37 / 8646 / 2824M17M
Q1 2026206134M37.3%48 / 6747 / 1730M22M
Q4 2025179136M38.1%36 / 7832 / 1947M22M
Q3 2025167112M31.3%39 / 5043 / 1846M16M
Q2 202514782M23.0%23 / 4533 / 138M6M
Q1 202513880M22.4%23 / 3442 / 179M4M
Q4 202413376M21.2%26 / 4228 / 195M5M
Q3 202412776M21.3%16 / 3732 / 1728M3M
Q2 202413062M17.3%16 / 4238 / 133M6M
Q1 202412965M18.2%9 / 3545 / 155M5M
Q4 202313765M18.2%18 / 3544 / 1910M5M
Q3 202313861M16.9%13 / 4138 / 128M5M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

149 funds held PGEN in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of PGENValue% of fundAs of
Patient Opportunity Trust12,900,0003.60%$73.53M3.66%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF7,085,5161.98%$40.39M0.38%Jun 30, 2026
Vanguard Total Stock Market Index Fund5,690,7961.59%$32.44M0.00%Jun 30, 2026
iShares Russell 2000 ETF4,955,7441.38%$28.25M0.03%Jun 30, 2026
Fidelity Small Cap Index Fund2,109,4120.59%$13.23M0.04%Jul 31, 2026
Vanguard Extended Market Index Fund2,020,2380.56%$11.52M0.01%Jun 30, 2026
iShares Russell 2000 Growth ETF1,782,2180.50%$10.16M0.07%Jun 30, 2026
Fidelity Small Cap Growth Fund1,678,3230.47%$10.52M0.12%Jul 31, 2026
First Trust Small Cap Growth AlphaDEX Fund1,539,5580.43%$9.65M0.74%Jul 31, 2026
iShares Biotechnology ETF1,116,8720.31%$6.37M0.07%Jun 30, 2026
Vanguard Russell 2000 Index Fund926,3700.26%$4.02M0.02%May 31, 2026
Fidelity Extended Market Index Fund915,3220.26%$3.97M0.01%May 31, 2026
Fidelity Small Cap Growth K6 Fund870,5900.24%$5.46M0.12%Jul 31, 2026
Schwab U.S. Small-Cap ETF839,3930.23%$3.64M0.02%May 31, 2026
First Trust Small Cap Core AlphaDEX Fund765,2060.21%$4.80M0.35%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Harry Thomasian Jr.Chief Financial Officer311,9110.09%Sep 24, 2026
Donald P. LehrChief Legal Officer758,1810.21%Aug 25, 2026
Phil TennantChief Commercial Officer221,1580.06%Aug 25, 2026
Helen SabzevariPresident and CEO3,789,7051.06%Aug 25, 2026
Rutul R. ShahChief Operating Officer468,8650.13%Aug 25, 2026
Jeffrey B. KindlerDirector17,1000.00%Aug 28, 2026
Nancy H. AgeeDirector309,1870.09%Aug 25, 2026
Randal J. KirkDirector, 10% owner116,301,09032.48%Mar 31, 2026
Vinita D. GuptaDirector669,0270.19%Mar 16, 2026
Fred HassanDirector1,243,2390.35%Mar 16, 2026
Cesar L. AlvarezDirector782,9090.22%Mar 16, 2026
Steven FrankDirector1,226,3910.34%Mar 16, 2026
James S. TurleyDirector685,4170.19%Mar 16, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Harry Thomasian Jr.
Chief Financial Officer
Sep 23, 2026Option exercise+42,918$2.33$100.00K311,911
Harry Thomasian Jr.
Chief Financial Officer
Sep 23, 2026Option exercise+2$0.96$2311,913
Harry Thomasian Jr.
Chief Financial Officer
Sep 23, 2026Option exercise+1$1.21$1311,914
Harry Thomasian Jr.
Chief Financial Officer
Sep 23, 2026Option exercise+10,744$4.72$50.71K268,993
Jeffrey B. Kindler
Director
Aug 26, 2026Sale−185,000$7.44$1.38M17,100
Phil Tennant
Chief Commercial Officer
Aug 25, 2026Option exercise+79,166$1.61$127.46K221,158
Phil Tennant
Chief Commercial Officer
Aug 25, 2026Sale(10b5-1 plan)−79,166$7.50$593.75K141,992
Rutul R. Shah
Chief Operating Officer
Aug 25, 2026Sale(10b5-1 plan)−15,342$7.50$115.07K468,865
Rutul R. Shah
Chief Operating Officer
Aug 25, 2026Option exercise+15,342$2.33$35.75K484,207
Phil Tennant
Chief Commercial Officer
Aug 23, 2026Option exercise+5,208––144,577
Phil Tennant
Chief Commercial Officer
Aug 23, 2026Tax withholding−2,585$7.20$18.61K141,992
Rutul R. Shah
Chief Operating Officer
Aug 23, 2026Tax withholding−3,647$7.20$26.26K468,865
Rutul R. Shah
Chief Operating Officer
Aug 23, 2026Option exercise+7,500––472,512
Helen Sabzevari
President and CEO
Aug 23, 2026Option exercise+20,833––3,789,705
Helen Sabzevari
President and CEO
Aug 23, 2026Tax withholding−10,184$7.20$73.32K3,779,521
Harry Thomasian Jr.
Chief Financial Officer
Aug 23, 2026Tax withholding−3,577$7.20$25.75K258,249
Harry Thomasian Jr.
Chief Financial Officer
Aug 23, 2026Option exercise+7,291––261,826
Donald P. Lehr
Chief Legal Officer
Aug 23, 2026Tax withholding−2,488$7.20$17.91K758,181
Donald P. Lehr
Chief Legal Officer
Aug 23, 2026Option exercise+5,208––760,669
Rutul R. Shah
Chief Operating Officer
Aug 21, 2026Sale(10b5-1 plan)−34,658$7.50$259.94K465,012
Rutul R. Shah
Chief Operating Officer
Aug 21, 2026Option exercise+34,658$2.33$80.75K499,670
Nancy H. Agee
Director
Aug 21, 2026Buy+3,411$7.23$24.66K309,187
Rutul R. Shah
Chief Operating Officer
Aug 6, 2026Sale(10b5-1 plan)−32,739$6.86$224.59K465,012
Rutul R. Shah
Chief Operating Officer
Aug 3, 2026Option exercise+33,772$2.33$78.69K531,523
Rutul R. Shah
Chief Operating Officer
Aug 3, 2026Sale(10b5-1 plan)−33,772$6.50$219.52K497,751
Harry Thomasian Jr.
Chief Financial Officer
Jul 31, 2026Sale(10b5-1 plan)−100,000$6.06$606.00K254,535
Harry Thomasian Jr.
Chief Financial Officer
Jul 1, 2026Sale(10b5-1 plan)−171,429$5.53$948.00K354,535
Helen Sabzevari
President and CEO
Jun 29, 2026Sale(10b5-1 plan)−346,836$5.89$2.04M3,768,872
Helen Sabzevari
President and CEO
Jun 29, 2026Option exercise+346,836$2.33$808.13K4,115,708
Harry Thomasian Jr.
Chief Financial Officer
Jun 29, 2026Sale(10b5-1 plan)−28,571$5.78$165.14K525,964
Rutul R. Shah
Chief Operating Officer
Jun 29, 2026Sale(10b5-1 plan)−42,924$5.85$251.11K497,751
Rutul R. Shah
Chief Operating Officer
Jun 29, 2026Option exercise+42,924$2.33$100.01K540,675
Phil Tennant
Chief Commercial Officer
May 28, 2026Sale−30,272$4.36$131.99K139,369
Donald P. Lehr
Chief Legal Officer
May 28, 2026Sale−29,131$4.36$127.01K755,461
Harry Thomasian Jr.
Chief Financial Officer
May 28, 2026Sale−41,884$4.36$182.61K554,535
Rutul R. Shah
Chief Operating Officer
May 28, 2026Sale−42,703$4.36$186.19K497,751
Helen Sabzevari
President and CEO
May 28, 2026Sale−119,250$4.36$519.93K3,768,872
Helen Sabzevari
President and CEO
May 23, 2026Option exercise+250,000––3,888,122
Phil Tennant
Chief Commercial Officer
May 23, 2026Option exercise+62,500––169,641
Harry Thomasian Jr.
Chief Financial Officer
May 23, 2026Option exercise+87,500––596,419
Donald P. Lehr
Chief Legal Officer
May 23, 2026Option exercise+62,500––784,592
Rutul R. Shah
Chief Operating Officer
May 23, 2026Option exercise+90,000––540,454
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−1,108,998$3.30$3.66M80,672,818
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−38,976$3.30$128.62K302,213
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−2,334,420$3.30$7.70M12,262,741
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−23,789$3.30$78.50K423,984
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−50,797$3.30$167.63K426,695
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−370,847$3.30$1.22M3,238,210
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−152,063$3.30$501.81K1,463,571
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−50,797$3.30$167.63K425,732
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−426,199$3.30$1.41M3,358,917
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−168,794$3.30$557.02K1,425,544
Randal J. Kirk
Director, 10% owner
Mar 30, 2026Sale−47,101$3.30$155.43K519,061
Helen Sabzevari
President and CEO, Director
Mar 18, 2026Option exercise+321,100––3,638,122
Phil Tennant
Chief Commercial Officer
Mar 18, 2026Option exercise+42,110––107,141
Donald P. Lehr
Chief Legal Officer
Mar 18, 2026Option exercise+40,443––722,092
Rutul R. Shah
Chief Operating Officer
Mar 18, 2026Option exercise+44,495––450,454
Harry Thomasian Jr.
Chief Financial Officer
Mar 18, 2026Option exercise+40,293––508,919
Randal J. Kirk
Director, 10% owner
Mar 13, 2026Option exercise+143,678––81,781,816
James S. Turley
Director
Mar 13, 2026Option exercise+71,839––685,417

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
22.77%
45M shares short
Days to cover
8.6
At 5M shares a day
Change since last report
-3.2%
From 46M shares
Short volume, 20 days
48.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Precigen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 113,406 shares on Aug 28, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Jeffrey B. Kindler
Director
Aug 26, 2026185,000$1.37MAug 26, 2026Acquired as compensation -- Restricted Stock Units
Phil Tennant
Officer
Aug 25, 202679,166$593.75KAug 25, 2026Stock Option Exercise
Rutul R. Shah
Officer
Aug 25, 202615,342$115.07KAug 25, 2026Stock Option Exercise
Rutul R. Shah
Officer
Aug 21, 202634,658$259.94KAug 21, 2026Stock Option Exercise
Rutul R. Shah
Officer
Aug 6, 202632,739$224.59KAug 6, 2026Restricted Stock Vesting
Rutul R. Shah
Officer
Aug 3, 202633,772$219.52KAug 3, 2026Stock Option Exercise
Harry Thomasian Jr.
Officer
Jul 31, 2026100,000$605.61KJul 31, 2026Restricted Stock Vesting
Harry Thomasian Jr.
Officer
Jul 1, 2026171,429$948.54KJul 1, 2026Restricted Stock Vesting
Harry Thomasian Jr.
Officer
Jun 29, 202628,571$165.20KJun 29, 2026Open Market Purchase
Rutul R. Shah
Officer
Jun 29, 202642,924$251.11KJun 29, 2026Stock Option Exercise
Helen Sabzevari
Officer, Director
Jun 29, 2026346,836$2.04MJun 29, 2026Stock Option Exercise
Randal J. Kirk
Director, 10% Shareholder
Mar 30, 20264,772,781$17.52MMar 30, 2026Private Placement
Randal J. Kirk
Director, 10% Shareholder
Dec 22, 20251,900,036$8.21MDec 22, 2025Secondary Public Offering
Jeffrey B. Kindler
Director
Dec 12, 2025235,467$868.87KDec 12, 2025Acquired as compensation -- Restricted Stock Units
Randal J. Kirk
Director, 10% Stockholder
Nov 20, 2025942,832$3.84MNov 20, 2025Public offering of shares by Company

Congress trades

4 trades in Precigen reported by 2 members of the House

MemberTypeTradedAmountFiled
Thomas Suozzi
NY03
SoldDec 14, 2018$1K–15KSep 23, 2021
1014 days late
Thomas Suozzi
NY03
BoughtDec 6, 2017$1K–15KSep 23, 2021
1387 days late
William L. Owens
NY21
SoldSep 8, 2014$1K–15KSep 10, 2014
William L. Owens
NY21
SoldMay 12, 2014$1K–15KMay 20, 2014

See a number that looks wrong?